Iroko Pharmaceuticals
One Kew Place
150 Rouse Boulevard
Philadelphia
Pennsylvania
19112
United States
Tel: 267-546-3003
Fax: 267-546-3004
Website: https://www.iroko.com/
81 articles about Iroko Pharmaceuticals
-
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
10/31/2018
Anticipates projected pro forma annual net revenue of between $80 and $90 million.
-
Philadelphia Drugmaker Iroko Pharma Pink Slips Another 122 Employees
6/5/2017
-
Iroko Pharma Announces Key Patent For VIVLODEX
1/6/2017
-
Iroko Pharma Provides Update In Relation To Zorvolex
12/7/2016
-
Iroko Pharma Slashes a Quarter of Workforce, But Plans to Hire 90 Sales Reps
9/21/2016
-
Iroko Pharmaceuticals Secures Debt Financing From CRG
6/29/2016
-
Iroko Pharmaceuticals Summarizes Low-Dose SoluMatrix NSAID Efficacy And Safety Data At American Association Of Nurse Practitioners National Conference
6/23/2016
-
Iroko Pharmaceuticals Release: New Data Shows That VIVLODEX Reduces Rescue Medication Use In Patients With Osteoarthritis Pain
5/12/2016
-
Iroko Pharmaceuticals Release: Survey Finds 8 In 10 Americans Experience Different Forms Of Pain But Many Are Unable To Effectively Control It
4/7/2016
-
Iroko Pharmaceuticals To Present Phase 3 VIVLODEX Efficacy And Safety Data At World Congress Of Osteoarthritis
3/31/2016
-
Iroko Pharmaceuticals Release: VIVLODEX Now Available In U.S. Pharmacies For The Management Of Osteoarthritis Pain
2/16/2016
-
Iroko Pharmaceuticals Receives FDA Approval For VIVLODEX - First Low Dose SoluMatrix Meloxicam For Osteoarthritis Pain
10/23/2015
-
Iroko Pharmaceuticals Announces Eighth International Licensing Agreement For ZORVOLEX
7/15/2015
-
Iroko Pharmaceuticals Release: TIVORBEX Now Available In U.S. Pharmacies For The Treatment Of Acute Pain
6/29/2015
-
Iroko Pharmaceuticals Announces First International Launch Of ZORVOLEX
5/14/2015
-
Iroko Pharmaceuticals Announces Additional International Licensing Agreement For ZORVOLEX
5/6/2015
-
Iroko Pharmaceuticals Granted New Patent For ZORVOLEX
4/29/2015
-
Iroko Pharmaceuticals Appoints New Member To Company’s Board Of Directors
4/1/2015
-
Iroko Pharmaceuticals Announces Acceptance Of U.S. Filing For Solumatrix Meloxicam In Osteoarthritis Pain
3/12/2015
-
Iroko Pharmaceuticals Announces International Regulatory Approval For ZORVOLEX®
12/10/2014